< Back to search trials

A Phase II, Single Arm Study Assessing the Efficacy of Osimertinib in Combination with Savolitinib in Patients with EGFRm+ and MET+, Locally Advanced or Metastatic Non-Small Cell Lung Cancer who have Progressed Following Treatment with Osimertinib (The SAVANNAH Study)

  • Clinicaltrials.gov #: NCT03778229
  • Acronym: SAVANNAH
  • Tumor Type: Lung
  • Tumor Subtype: Non-Small Cell Lung Cancer
  • Tumor Stage: N/A
  • Type of Treatment: